C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?

J Rheumatol. 1996 Feb;23(2):378-81.

Abstract

We report the coincidence of hereditary angioedema and rheumatoid arthritis in a male patient and in his father. During treatment with D-penicillamine the patient developed a transient lupus-like disorder with glomerulonephritis that resolved when D-penicillamine was discontinued. He later was diagnosed with malignant lymphoma. Impaired classical complement pathway function could have contributed to development of the drug reaction.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioedema / complications
  • Angioedema / genetics
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Child
  • Complement C1 Inactivator Proteins / deficiency*
  • Glomerulonephritis / chemically induced
  • Glomerulonephritis / pathology
  • Humans
  • Lupus Erythematosus, Systemic / chemically induced
  • Male
  • Penicillamine / adverse effects*
  • Penicillamine / therapeutic use
  • Risk Factors

Substances

  • Complement C1 Inactivator Proteins
  • Penicillamine